Cybercriminal activity continues to move away from direct software exploitation toward manipulating everyday user behavior within corporate environments, experts have warned. New research by Huntress ...

A cancer support group helped spread the message for men to get checked during an event at a West Lothian supermarket. The West Lothian Prostate Cancer Support Group Team hosted an amazing event held ...

Add Yahoo as a preferred source to see more of our stories on Google. A cancer support group helped spread the message for men to get checked during an event at a West Lothian supermarket. The West ...

This week, cancer researchers in New York are one step closer to answering a question that has plagued medical and environmental advocates for decades: What is the role of plastic exposure in the ...

Overall survival from the phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in first-line metastatic castration-resistant prostate cancer (mCRPC) with DNA repair defects (BRCAAway).

Please provide your email address to receive an email when new articles are posted on . Pylarify TruVu is a new formulation of piflufolastat F 18 injection, which originally earned FDA approval in ...

Longtime friends and allies of Joe Biden say they are worried about the toll an aggressive form of prostate cancer is taking on the former president and his health. But Biden and his aides say he is ...

Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center ...

- Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues - Adam Pearson, Chief Strategy Officer, Astellas"Astellas is proud to have ...

Triumph reveals new Distinguished Gentleman's Ride 2026 apparel collection, including nine products. What's even cooler than the collection is that proceeds are going to the cause. As a coordinated ...

– Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date – Dose-dependent ...